Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 2/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.50 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.45 |
| ▸ | WDR5 | P61964 | 5/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | MLLT1 | Q03111 | 1/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26703812 | 0.91 | PTGIR (0.48) | PTGIRADRA2ANISCHWDR5MLLT1 | |
| SCHEMBL10054979 | 0.87 | PTGIR (0.69) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| SCHEMBL17186490 | 0.83 | PTGIR (0.61) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| Hydrochloric Acid SCHEMBL18605409 | 0.81 | PTGIR (0.59) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| SCHEMBL4032956 | 0.81 | PTGIR (0.62) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| SCHEMBL26703926 | 0.80 | PTGIR (0.61) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| SCHEMBL4035161 | 0.80 | PTGIR (0.61) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| SCHEMBL10800812 | 0.80 | PTGIR (0.83) | PTGIRADRA2AADRA2BADRA2CWDR5 | |
| SCHEMBL3169468 | 0.79 | PTGIR (0.60) | PTGIRADRA2ANISCHADRA2BADRA2C | |
| SCHEMBL28904914 | 0.76 | PTGIR (0.64) | PTGIRADRA2ANISCHADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120081848-A | Imidazo-containing pyrimidinone derivative, and preparation method and application thereof | 贵州大学 | 2025-06-03 | — | — | CN | disclosed |
| US-20230339947-A1 | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS | Madera Therapeutics, LLC | 2023-10-26 | — | — | US | disclosed |
| US-20230339947-A1 | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS | Madera Therapeutics, LLC | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339947-A1 | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS | CLPP, PRCP, PREP | PTGIR 2672/4885ADRA2A 4039/4885NISCH 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.